Product Images Oxcarbazepine

This is a medication called Oxcarbazepine, available in a quantity of 100 HD2 and is for prescription only. The packaging has the NDC number 70518-1842-01 and indicates that it should be stored at a temperature between 20-26°C (63-77°F) with permitted excursions up to 15-30°C (59-86°F). The medication has been repackaged by RemedyRepack Inc., located in Indiana. The package insert should be followed for directions on how to use the medication. The medication expires and has a lot number, but these are not visible in the output. The manufacturer of the medication is Sun Pharma, located in Cranbury, New Jersey. A warning is given to keep this medication and all other medications out of the reach of children.*

This is a prescription drug called Oxcarbazepine. It comes in a HD2 quantity and should be kept out of the reach of children. It is repackaged by a company called RemedyRepack Inc. The label provides the NDC number, lot number, and source NDC of the medication. The manufacturer is Sun Pharma and it should be stored at a temperature between 20-26°C. Directions for use can be found in the package insert.*

This is a prescription medication called Oxcarbazepine with a quantity of 30 HD2 tablets in the package. The prescription label has important details such as the NDC number and Lot number, and indicates that it is manufactured by Sun Pharma in New Jersey. The directions for use are on the package insert, and it should be stored at a temperature of 20-26°C. The medication was repackaged by RemedyRepack Inc. in Indiana, Pennsylvania.*

The figure 1 shows Kaplan Meier estimate of exit rate by treatment group. The plot shows the time on trial for a duration of 11 days, where the treatment group includes Oxcarbazepine and Placebo. The log-rank test (P-value) shows a statistical significance of 0.0001, indicating that there is a significant difference between the treatment groups.*

The text describes a figure (Figure 2) which represents the Kaplan-Meier estimates of the first seizure event rate by treatment group. It also mentions the seizure rate and the p-value (0.046) obtained through a log-rank test. Below the results, the days from the first dose to the first seizure are presented and the two treatment groups (Oxcarbazepine and Placebo) are compared.*

The image shows Kaplan-Meier Estimates of Exit Rate by Treatment Group. The graph represents the exit rate on the y-axis, while the x-axis shows the time to exit in days. The treatment group is divided into a high and low group, while the exit rate is recorded as 0.1 through 0.9. The graph also shows a log-rank test, stating a p-value of 0.0001.*

This text describes a figure showing Kaplan-Meier Estimates of Exit Rate by Treatment Group. It includes a log-rank test with a p-value of 0.0001. There is also some illegible text at the bottom. The figure shows the time to exit (in days) for a high and low treatment group.*